Biotech · Public company · Austin, TX, US

Faeth Therapeutics, Inc.

Ticker FTH · SEC CIK 0001829802

Track this companyFree. Adds Faeth Therapeutics, Inc. to your Dealase workspace and tells you when its record changes.

Clinical trials52 recruiting or active

Pipeline programs11From trials and the company's site

Disclosed deals0None found yet

Cash runwayNot availableNo recent cash burn filed

Pipeline11

FulvestrantPhase 2 · HR+ HER2- Breast CancerClinicalTrials.gov · fetched Nov 12, 2026
PaclitaxelPhase 2 · Endometrial CancerClinicalTrials.gov · fetched Nov 12, 2026
sapanisertibPhase 2 · Non-Small Cell Lung CancerClinicalTrials.gov · fetched Nov 12, 2026
SapanisertibPhase 2 · Endometrial CancerClinicalTrials.gov · fetched Nov 12, 2026
SapanisertibPhase 2 · HR+ HER2- Breast CancerClinicalTrials.gov · fetched Nov 12, 2026
SerabelisibPhase 2 · HR+ HER2- Breast CancerClinicalTrials.gov · fetched Nov 12, 2026
SerabelisibPhase 2 · Endometrial CancerClinicalTrials.gov · fetched Nov 12, 2026
Insulin Suppressing DietPhase 1 · Advanced Solid TumorClinicalTrials.gov · fetched Nov 12, 2026
Nab paclitaxelPhase 1 · Advanced Solid TumorClinicalTrials.gov · fetched Nov 12, 2026
SerabelisibPhase 1 · Advanced Solid TumorClinicalTrials.gov · fetched Nov 12, 2026
NEAAR Medical FoodMetastatic Pancreatic AdenocarcinomaClinicalTrials.gov · fetched Nov 12, 2026

Sapanisertib and Serabelisib (PIKTOR) in Various Combinations in Patients With HR+/HER2- Advanced/Metastatic Breast CancerPHASE1_PHASE2 · RECRUITING · started Apr 22, 2026ClinicalTrials.gov NCT07558733 · fetched Nov 12, 2026
Sapanisertib and Serabelisib (PIKTOR) With Paclitaxel and a Substudy With an Insulin-Suppressing Diet in Patients With Advanced/Recurrent Endometrial CancerPHASE2 · RECRUITING · started Dec 12, 2024ClinicalTrials.gov NCT06463028 · fetched Nov 12, 2026
A Study of Sapanisertib in Relapsed/Refractory NFE2L2-Mutated and Wild-Type Squamous Non-Small Cell Lung CancerPHASE2 · TERMINATED · started Jul 21, 2022ClinicalTrials.gov NCT05275673 · fetched Nov 12, 2026
Combination of Serabelisib and Insulin Suppressing Diet With or Without Nab-paclitaxel in Subjects With Advanced Solid Tumors With PIK3CA MutationsPHASE1 · TERMINATED · started Apr 22, 2022ClinicalTrials.gov NCT05300048 · fetched Nov 12, 2026
Medical Food for the Dietary Management of Advanced/Metastatic Pancreatic CancerNA · COMPLETED · started Dec 21, 2021ClinicalTrials.gov NCT05078775 · fetched Nov 12, 2026